Nivolumab ± ipilimumab treatment (Tx) efficacy, safety, and biomarkers in patients (Pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): results from the CheckMate-142 study

  1. Overman, M.J.
  2. Kopetz, S.
  3. Lonardi, S.
  4. McDermott, R.
  5. Leone, F.
  6. Leach, J.
  7. Lenz, H.-J.
  8. Hendlisz, A.
  9. Morse, M.
  10. Garcia-Alfonso, P.
  11. Desai, J.
  12. Hill, A.
  13. Moss, R.A.
  14. Goldberg, M.V.
  15. Lin, C.-S.
  16. Tang, H.
  17. André, T.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2016

Alea: 27

Orrialdeak: vi158

Mota: Artikulua

DOI: 10.1093/ANNONC/MDW370.27 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus